Evaluating the efficacy and safety of milrinone for prevention of post-patent ductus arteriosus closure syndrome (the MIDAS trial) in extremely preterm infants: a multicentre, double-masked, randomised, placebo-controlled trial

Introduction Post-ligation cardiac syndrome (PLCS) represents a state of severe post-intervention cardiopulmonary instability, seen in up to 50% of extremely premature infants after surgical closure of the patent ductus arteriosus (PDA); yet an evidence-based approach to treatment of this condition...

Полное описание

Библиографические подробности

Главные авторы:	Anup C Katheria, Abhik Das, Susan R Hintz, Edward F Bell, Tarah T Colaizy, Karen J Johnson, Cheryl Battersby, Philip T Levy, Matthew M Laughon, Felix Ines, Patrick J McNamara, Shazia Bhombal, Valerie Y Chock, Heidi M Harmon, Matthew A Rysavy, Adrianne Rahde-Bischoff, Jenna Gabrio, Diana Montoya-Williams, Keira Sorrells, Ben Carper
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMJ Publishing Group 2025-08-01
Серии:	BMJ Open
Online-ссылка:	https://bmjopen.bmj.com/content/15/8/e105018.full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!